These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 24772414)

  • 41. Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy.
    Fu Z; Xiang J
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force.
    Wang Z; Zhi K; Ding Z; Sun Y; Li S; Li M; Pu K; Zou J
    Semin Cancer Biol; 2021 Feb; 69():77-90. PubMed ID: 31962173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Self-Assembled Nanocarriers Based on Amphiphilic Natural Polymers for Anti- Cancer Drug Delivery Applications.
    Sabra S; Abdelmoneem M; Abdelwakil M; Mabrouk MT; Anwar D; Mohamed R; Khattab S; Bekhit A; Elkhodairy K; Freag M; Elzoghby A
    Curr Pharm Des; 2017; 23(35):5213-5229. PubMed ID: 28552068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery.
    Gou M; Wei X; Men K; Wang B; Luo F; Zhao X; Wei Y; Qian Z
    Curr Drug Targets; 2011 Jul; 12(8):1131-50. PubMed ID: 21443476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Caged protein nanoparticles for drug delivery.
    Molino NM; Wang SW
    Curr Opin Biotechnol; 2014 Aug; 28():75-82. PubMed ID: 24832078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aminoglycoside-derived amphiphilic nanoparticles for molecular delivery.
    Miryala B; Godeshala S; Grandhi TS; Christensen MD; Tian Y; Rege K
    Colloids Surf B Biointerfaces; 2016 Oct; 146():924-37. PubMed ID: 27472455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selenium nanoparticles: potential in cancer gene and drug delivery.
    Maiyo F; Singh M
    Nanomedicine (Lond); 2017 May; 12(9):1075-1089. PubMed ID: 28440710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Appraisal on Various Methods of Nano Particulate Formulations.
    Dhiman B; Divtrannum ; Dhiman A; Saini S
    Pharm Nanotechnol; 2017; 5(4):255-262. PubMed ID: 29119943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.
    Meng F; Han N; Yeo Y
    Expert Opin Drug Deliv; 2017 Mar; 14(3):427-446. PubMed ID: 27476442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymer nanoparticles for the intravenous delivery of anticancer drugs: the checkpoints on the road from the synthesis to clinical translation.
    Ferrari R; Sponchioni M; Morbidelli M; Moscatelli D
    Nanoscale; 2018 Dec; 10(48):22701-22719. PubMed ID: 30512025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
    Sultana S; Khan MR; Kumar M; Kumar S; Ali M
    J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.
    Marchal S; El Hor A; Millard M; Gillon V; Bezdetnaya L
    Drugs; 2015 Sep; 75(14):1601-11. PubMed ID: 26323338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reporter nanoparticle that monitors its anticancer efficacy in real time.
    Kulkarni A; Rao P; Natarajan S; Goldman A; Sabbisetti VS; Khater Y; Korimerla N; Chandrasekar V; Mashelkar RA; Sengupta S
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):E2104-13. PubMed ID: 27036008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanoscale poly(4-hydroxybutyrate)-mPEG carriers for anticancer drugs delivery.
    Shah M; Ullah N; Choi MH; Yoon SC
    J Nanosci Nanotechnol; 2014 Nov; 14(11):8416-21. PubMed ID: 25958538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B
    Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds.
    Ackova DG; Smilkov K; Bosnakovski D
    Recent Pat Anticancer Drug Discov; 2019; 14(1):19-31. PubMed ID: 30636616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
    Ranjbari J; Mokhtarzadeh A; Alibakhshi A; Tabarzad M; Hejazi M; Ramezani M
    Curr Pharm Des; 2018 Feb; 23(39):6019-6032. PubMed ID: 28482782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glyco-nanoparticles: New drug delivery systems in cancer therapy.
    Khan H; Mirzaei HR; Amiri A; Kupeli Akkol E; Ashhad Halimi SM; Mirzaei H
    Semin Cancer Biol; 2021 Feb; 69():24-42. PubMed ID: 31870939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.